Alan Kotok<p>Engineered T-Cells Shown Safe, Reduce Myasthenia Gravis</p><p>Results of a small clinical trial show genetically altered T-cells from patients with myasthenia gravis are well tolerated and reduce symptoms of the disease. </p><p><a href="https://sciencebusiness.technewslit.com/?p=44933" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://</span><span class="ellipsis">sciencebusiness.technewslit.co</span><span class="invisible">m/?p=44933</span></a> </p><p><a href="https://journa.host/tags/News" class="mention hashtag" rel="tag">#<span>News</span></a> <a href="https://journa.host/tags/Science" class="mention hashtag" rel="tag">#<span>Science</span></a> <a href="https://journa.host/tags/Business" class="mention hashtag" rel="tag">#<span>Business</span></a> <a href="https://journa.host/tags/MyastheniaGravis" class="mention hashtag" rel="tag">#<span>MyastheniaGravis</span></a> <a href="https://journa.host/tags/Autoimmune" class="mention hashtag" rel="tag">#<span>Autoimmune</span></a> <a href="https://journa.host/tags/ClinicalTrial" class="mention hashtag" rel="tag">#<span>ClinicalTrial</span></a> <a href="https://journa.host/tags/Biotechnology" class="mention hashtag" rel="tag">#<span>Biotechnology</span></a> <a href="https://journa.host/tags/Tcells" class="mention hashtag" rel="tag">#<span>Tcells</span></a> <a href="https://journa.host/tags/Autologous" class="mention hashtag" rel="tag">#<span>Autologous</span></a></p>